$TMCI News

Treace to Report Third Quarter 2026 Financial Results on November 6, 2026

Treace Medical (TMCI) Reports Five-Year Bunion Results. Can Evidence Drive Adoption?

Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

Treace Medical Presents 5-Year ALIGN3D Data Showing 0.8% Recurrence Rate Alongside MTA3D And SPRINT Clinical Results At AOFAS 2026

Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting

Treace Medical (TMCI) Q2 2026 Earnings Call Transcript

Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5

Treace Medical Concepts Inc (TMCI) (Q2 2026) Earnings Call Highlights: Revenue Declines 4% but ...

Treace Medical Concepts Q2 Earnings Call Highlights

Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript

Treace Medical Concepts (NASDAQ:TMCI) Rises as Q2 Loss Narrows, Revenue Matches Estimates

Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

Treace Medical Concepts Q2 EPS $(0.24) Beats $(0.30) Estimate, Sales $45.376M Beat $44.020M Estimate

Treace Medical Concepts Raises FY2026 Sales Guidance from $202.000M-$212.000M to $204.000M-$212.000M vs $206.220M Est

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $4

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

Treace Medical Concepts Announces Completion Of First Case Utilizing Its HyperPlate XM Dynamic Compression Locking Implant, Complete Commercialization Expected in Q3 of 2026

Treace to Present at the Sidoti Small Cap Conference